¼¼°èÀÇ È¯ÀÚ Ç÷¾× °ü¸® ½ÃÀåÀº 2030³â±îÁö 236¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á
2023³â¿¡ 152¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ È¯ÀÚ Ç÷¾× °ü¸® ½ÃÀåÀº 2023-2030³â CAGR 6.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 236¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ±â±â´Â CAGR 6.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 101¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½Ã¾à¡¤Å°Æ® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ÀÇ CAGR·Î 7.1%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 40¾ï ´Þ·¯, Áß±¹Àº CAGR 9.8%·Î ¼ºÀå ¿¹Ãø
¹Ì±¹ÀÇ È¯ÀÚ Ç÷¾× °ü¸® ½ÃÀåÀº 2023³â¿¡ 40¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 9.8%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â ¿¹Ãø ½ÃÀå ±Ô¸ð°¡ 56¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.3%¿Í 5.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ CAGR 3.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ È¯ÀÚ Ç÷¾× °ü¸® ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®
Çö´ë ÇコÄɾ¼ ȯÀÚ Ç÷¾× °ü¸®°¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â?
ȯÀÚ Ç÷¾× °ü¸®(PBM)´Â ¼öÇ÷ÀÌ ÇÊ¿äÇÑ È¯ÀÚÀÇ Ä¡·á¸¦ ÃÖÀûÈÇϱâ À§ÇÑ Ã¼°èÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÔÀ¸·Î½á Çö´ë ÀÇ·á¿¡¼ ¸Å¿ì Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸® Àâ¾ÒÀ¸¸ç, ºóÇ÷À» °ü¸®ÇÏ°í ¼ö¼ú Áß ÃâÇ÷À» ÁÙÀ̸ç ȯÀÚÀÇ ÀûÇ÷±¸ ¼öÄ¡¸¦ ÃÖÀûÈÇÏ¿© ¼öÇ÷ÀÇ Çʿ伺À» ÃÖ¼ÒÈÇÏ°í °¨¿°, ¸é¿ª ¹ÝÀÀ, ¼öÇ÷ °ü·Ã ÇÕº´Áõ µî ¼öÇ÷°ú °ü·ÃµÈ À§ÇèÀ» ÁÙÀÓÀ¸·Î½á ȯÀÚÀÇ ¾ÈÀü°ú ÀÓ»ó °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. PBMÀÇ Á߿伺Àº °¨¿°, ¸é¿ª ¹ÝÀÀ, ¼öÇ÷ °ü·Ã ÇÕº´Áõ µî ¼öÇ÷°ú °ü·ÃµÈ À§ÇèÀ» ÁÙ¿© ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½ÃŰ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°Å ±â¹Ý Á¢±Ù¹ýÀº Ç÷¾×Á¦Á¦¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß°í Á¶±â ȸº¹À¸·Î À̾îÁö±â ¶§¹®¿¡ ¼ö¼ú, ¿Ü»ó, ¸¸¼º ºóÇ÷ ȯÀÚ¿¡°Ô ƯÈ÷ Áß¿äÇÕ´Ï´Ù.
PBMÀº ºÒÇÊ¿äÇÑ ¼öÇ÷À» ÃÖ¼ÒÈÇÔÀ¸·Î½á °¡¿ë·®ÀÌ Á¦ÇÑÀûÀÎ Ç÷¾× °ø±ÞÀ» Àý¾àÇÏ´Â µ¥¿¡µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº ƯÈ÷ Ç÷¾×ÀÌ ºÎÁ·Çϰųª Ç÷¾×Á¦Á¦¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇÑµÈ Áö¿ªÀÇ ÀÇ·á ½Ã½ºÅÛ¿¡ ÇʼöÀûÀÔ´Ï´Ù. Àα¸ °í·ÉÈ¿Í ¼ö¼ú Áõ°¡·Î ÀÎÇØ Ç÷¾×¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â °¡¿îµ¥, PBMÀº Ç÷¾×À» °¡Àå ÇÊ¿ä·Î Çϴ ȯÀÚ¿¡°Ô Ç÷¾×ÀÌ °ø±ÞµÉ ¼ö ÀÖµµ·Ï ÇÏ¸é¼ È¿À²ÀûÀÎ Ç÷¾× »ç¿ëÀ» Àå·ÁÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °üÇàÀº ÀÚ¿øÀ» Àý¾àÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¼öÇ÷°ú °ü·ÃµÈ ÀÇ·á ºñ¿ëÀ» ³·Ãç PBMÀ» Áö¼Ó°¡´ÉÇÑ ÀÇ·á °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ¸¸µé°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ PBMÀº °¢ ȯÀÚÀÇ Ç÷¾× ¼ö¿ä¸¦ °ü¸®Çϱâ À§ÇØ ¿¹¹æÀûÀÌ°í °³º°ÈµÈ Á¢±Ù ¹æ½ÄÀ» ÃëÇÔÀ¸·Î½á Àü¹ÝÀûÀÎ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. PBMÀº öºÐ º¸Ãæ, ÀûÇ÷±¸ Á¶Ç÷ ÃËÁøÁ¦, °í±Þ ¼ö¼ú ±â¹ý µîÀÇ °³ÀÔÀ» ÅëÇØ ¼ö¼úÀ̳ª Ä¡·á Àü¿¡ ȯÀÚ¸¦ ÃæºÐÈ÷ Áغñ½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀº ÇÕº´Áõ ¹ß»ý °¡´É¼ºÀ» ÁÙÀ̰í ÀÔ¿ø ±â°£À» ´ÜÃàÇϸç ȸº¹ ½Ã°£À» ¿¬ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á¿¡¼ ȯÀÚ Áß½ÉÀÇ Ä¡·á°¡ Á¡Á¡ ´õ Áß¿ä½ÃµÇ´Â °¡¿îµ¥ PBMÀº Çö´ë ÀÇ·á Á¦°øÀÇ ¿øÄ¢¿¡ µû¶ó ¸ÂÃãÇü ¿¹¹æ Àü·«À» Á¦°øÇÏ¿© ȯÀÚ ¸¸Á·µµ¿Í °Ç° °á°ú¸¦ ¸ðµÎ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.
±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô ȯÀÚÀÇ Ç÷¾× °ü¸®¸¦ °ÈÇϴ°¡?
±â¼úÀÇ ¹ßÀüÀº Ç÷¾× »ç¿ëÀ» ÃÖÀûÈÇϰí Ç÷¾× ¼Õ½ÇÀ» ÃÖ¼ÒÈÇϸç ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ´Â »õ·Î¿î Åø¿Í ¹æ¹ýÀ» µµÀÔÇÔÀ¸·Î½á ȯÀÚ Ç÷¾× °ü¸®¸¦ Å©°Ô °³¼±Çϰí ÀÖ½À´Ï´Ù. POC(Point-of-Care) °Ë»ç ¹× ÀÚµ¿ Ç÷¾× ºÐ¼®±â¿Í °°Àº ±â¼úÀº ½Å¼ÓÇÑ Çì¸ð±Û·Îºó Æò°¡ ¹× öºÐ °áÇÌ Æò°¡¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© ÀÇ·áÁøÀÌ ºóÇ÷À» Á¶±â¿¡ Áø´ÜÇϰí Ä¡·áÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. Á¤È®ÇÑ ½Ç½Ã°£ Áø´ÜÀ» ÅëÇØ ÀÓ»óÀÇ´Â Çì¸ð±Û·Îºó ¼öÄ¡¸¦ ÃÖÀûÈÇϱâ À§ÇÑ °³º°È Àü·«À» »çÀü¿¡ ½ÇÇàÇÏ¿© ¼öÇ÷ÀÌ ÇÊ¿äÇÒ °¡´É¼ºÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº PBMÀÇ ÇÙ½É ¿ä¼ÒÀÎ ¿¹¹æÀû ºóÇ÷ °ü¸®¸¦ Áö¿øÇÏ¿© ȯÀÚ°¡ Ä¡·á¸¦ ¹Þ±â Àü¿¡ ÃÖ»óÀÇ »óŸ¦ À¯ÁöÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù.
PBMÀÇ ¶Ç ´Ù¸¥ Å« ¹ßÀüÀº ¼ö¼ú Áß ÃâÇ÷À» ÃÖ¼ÒÈÇÏ°í ¼öÇ÷ÀÇ Çʿ伺À» °¨¼Ò½ÃŰ´Â ¼¼Æ÷ ȸ¼ö ¹× Ç÷¾× º¸Á¸ ¼ö¼ú ±â¹ýÀÇ »ç¿ëÀÔ´Ï´Ù. ¼ö¼ú Áß ¼¼Æ÷±¸Ãâ Àåºñ´Â ¼ö¼ú Áß È¯ÀÚÀÇ Ç÷¾×À» ȸ¼ö ¹× ó¸®ÇÏ¿© ȯÀÚ¿¡°Ô ´Ù½Ã ÁÖÀÔÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ±âÁõÀÚ Ç÷¾×¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãâ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃÖ¼Ò Ä§½À ¼ö¼ú°ú º¹°°æ ¼ö¼úÀº Àý°³Ã¢ÀÌ ÀÛ¾Æ ÃâÇ÷ÀÌ Àû±â ¶§¹®¿¡ Á¡Á¡ ´õ º¸Æíȵǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº Á¤Çü¿Ü°ú¼ö¼úÀ̳ª ½ÉÀå ¼ö¼ú°ú °°ÀÌ ÃâÇ÷ÀÌ ¸¹Àº ¼ö¼ú¿¡¼ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. PBMÀº ¼¼Æ÷ ȸ¼ö ¹× ÃÖ¼Ò Ä§½À ±â¼úÀ» µµÀÔÇÏ¿© ¿ÜºÎ Ç÷¾×ÀÇ Çʿ伺À» ÁÙÀ̰í, ¼ö¼ú °á°ú¸¦ °³¼±Çϸç, ÀÚ¿ø È¿À²¼ºÀ» Áö¿øÇÕ´Ï´Ù.
ÀûÇ÷±¸ Á¶Ç÷ÀÚ±ØÁ¦(ESA)¿Í öºÐ º¸ÃæÁ¦¿Í °°Àº ÀǾàǰ Çõ½Åµµ ÀûÇ÷±¸ »ý¼ºÀ» ÃËÁøÇÏ°í ¼öÇ÷ ¾øÀÌ ºóÇ÷À» Ä¡·áÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ESA´Â °ñ¼ö¸¦ ÀÚ±ØÇÏ¿© ´õ ¸¹Àº ÀûÇ÷±¸¸¦ »ý¼ºÇϵµ·Ï µµ¿ÍÁֱ⠶§¹®¿¡ ¸¸¼º ºóÇ÷ ȯÀÚ³ª ÈÇпä¹ýÀ» ¹Þ´Â ȯÀÚ¿¡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¸¸¼º ºóÇ÷ ȯÀÚ³ª ÈÇпä¹ýÀ» ¹Þ´Â ȯÀÚ¿¡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. öºÐ º¸ÃæÁ¦´Â °æ±¸ ¶Ç´Â Á¤¸Æ Áֻ縦 ÅëÇØ Çì¸ð±Û·ÎºóÀ» ÃÖÀûÈÇϰí ÃâÇ÷À» µ¿¹ÝÇÒ ¼ö ÀÖ´Â ½Ã¼ú¿¡ ´ëºñÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇϸç, PBMÀº ¼öÇ÷ÀÇ Çʿ伺À» ÃÖ¼ÒÈÇÏ¸é¼ È¯ÀÚÀÇ °Ç°À» ÁõÁø½ÃŲ´Ù´Â ¸ñÇ¥¿¡ µû¶ó ÀÌ·¯ÇÑ ¾à¹° ÁßÀ縦 ÅëÇØ ºóÇ÷ °ü¸®¸¦ À§ÇÑ ºñ¼öÇ÷ ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á¹ýÀº ÀÓ»óÀǰ¡ °¢ ȯÀÚÀÇ Çʿ信 µû¶ó PBM Àü·«À» Á¶Á¤ÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© Ç÷¾× °ü¸®¿¡ ´ëÇÑ º¸´Ù È¿°úÀûÀÌ°í ´ú ħ½ÀÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.
ȯÀÚÀÇ Ç÷¾× °ü¸®´Â ȯÀÚ¿Í ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ¾î¶² ÀÌÁ¡ÀÌ Àִ°¡?
ȯÀÚ Ç÷¾× °ü¸®´Â ȯÀÚ¿Í ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ ¸ðµÎ¿¡°Ô Å« ÀÌÁ¡À» Á¦°øÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±Çϰí ÀÇ·á ºñ¿ëÀ» Àý°¨Çϸç Á¦ÇÑµÈ Ç÷¾× ÀÚ¿øÀÇ »ç¿ëÀ» ÃÖÀûÈÇÕ´Ï´Ù. ȯÀÚÀÇ °æ¿ì, PBMÀº °¨¿°, ¼öÇ÷ ¹ÝÀÀ, ¸é¿ªÇÐÀû ÇÕº´Áõ°ú °°Àº ¼öÇ÷°ú °ü·ÃµÈ À§ÇèÀ» ÃÖ¼ÒÈÇÏ¿© ¾ÈÀü¼ºÀ» ³ôÀÔ´Ï´Ù. PBMÀº ºóÇ÷ °ü¸®, ¿Ü°úÀû º¸Á¸ ±â¼ú, ȯÀÚ ÀÚ½ÅÀÇ Ç÷¾× »ç¿ë µî ¼öÇ÷ ÀÌ¿ÜÀÇ °³ÀÔÀ» ÅëÇØ ºÎÀÛ¿ëÀÇ °¡´É¼ºÀ» ÁÙÀÌ°í º¸´Ù ¾ÈÀüÇÑ ÀÇ·á ¼ºñ½º¸¦ ÃËÁøÇÕ´Ï´Ù. ´ë¼ö¼úÀ» ¹Þ´Â ȯÀÚÀÇ °æ¿ì, PBMÀº ȯÀÚÀÇ °Ç°À» ¿ì¼±½ÃÇÏ°í ¼öÇ÷ÀÇ Çʿ伺À» ÁÙ¿© ȸº¹ ½Ã°£À» ´ÜÃàÇϰí ÀÔ¿ø ±â°£À» ´ÜÃàÇÒ ¼ö ÀÖµµ·Ï ¼¼½ÉÇÏ°Ô °ü¸®µÇ´Â Ç÷¾× Àü·«À» º¸ÀåÇÕ´Ï´Ù.
PBMÀº ÀÇ·á±â°üÀÇ °æ¿ì, °ø±ÞÀÌ Á¦ÇÑÀûÀÎ ÇåÇ÷ÀÚ Ç÷¾×¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãç È¿À²ÀûÀ̰í Áö¼Ó°¡´ÉÇÑ ÀÚ¿ø °ü¸®¸¦ µ½½À´Ï´Ù. ÇåÇ÷·üÀÌ ¼ö¿ä Áõ°¡¸¦ µû¶óÀâÁö ¸øÇÏ´Â »óȲ¿¡¼ PBMÀº ¿Ü»óÀ̳ª ÁßÁõ ÃâÇ÷ ȯÀÚ µî Áß¿äÇÑ Çʿ䰡 Àִ ȯÀÚµéÀ» À§ÇØ Ç÷¾× ÀÚ¿øÀ» È®º¸ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÃÖÀûÈµÈ Ä¡·á¿Í ¼öÇ÷ ÀÌ¿ÜÀÇ °³ÀÔÀ» ÅëÇØ Ç÷¾× »ç¿ë·®À» ÁÙÀÓÀ¸·Î½á ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ÀÚ¿øÀ»º¸´Ù È¿°úÀûÀ¸·Î °ü¸®ÇÏ¿© Ç÷¾× ºÎÁ· À§ÇèÀ» ³·Ãß°í ½ÇÁ¦·Î ÇÊ¿äÇÒ ¶§ Ç÷¾× Á¦Á¦¸¦ »ç¿ëÇÒ ¼ö ÀÖµµ·ÏÇÕ´Ï´Ù, ¼öÇ÷°ú °ü·ÃµÈ ºñ¿ëÀ» Àý°¨ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ë È¿À²¼ºÀº Ç÷¾× ÀÚ¿øÀ» È¿°úÀûÀ¸·Î °ü¸®ÇÔÀ¸·Î½á »ó´çÇÑ ÀçÁ¤Àû Àý°¨À¸·Î À̾îÁö´Â ´ë±Ô¸ð º´¿ø ¹× ÀÇ·á ½Ã½ºÅÛ¿¡¼ ƯÈ÷ °¡Ä¡°¡ ÀÖ½À´Ï´Ù.
PBMÀÇ ¶Ç ´Ù¸¥ ÀåÁ¡Àº ȯÀÚ °á°ú¿Í Ä¡·áÀÇ ÁúÀ» Çâ»ó½ÃÄÑ È¯ÀÚ Áß½ÉÀÇ °³º°ÈµÈ ÀÇ·á Á¢±ÙÀ» ÃËÁøÇÏ´Â °ÍÀÔ´Ï´Ù. PBMÀº ºóÇ÷ Á¶±â ¹ß°ß, Ç÷¾×À» Àý¾àÇÏ´Â ¼ö¼ú, ¼öÇ÷À» ÇÏÁö ¾Ê´Â ¼±Åà µîÀ» ÅëÇØ ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ°¡ °¢ ȯÀÚÀÇ Çʿ信 ¸Â´Â ¸ÂÃã Ä¡·á °èȹÀ» ¼¼¿ï ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ¸ÂÃãÇü Á¢±Ù ¹æ½ÄÀº ÇÕº´Áõ ¹ß»ý °¡´É¼ºÀ» ÁÙÀ̰í, ºü¸¥ ȸº¹À» Áö¿øÇϸç, ȯÀÚ ¸¸Á·µµ¿Í Àü¹ÝÀûÀÎ Ä¡·áÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ȯÀÚÀÇ Ç÷¾× °Ç° »óŸ¦ Àû±ØÀûÀ¸·Î °ü¸®ÇÔÀ¸·Î½á PBMÀº ÀÔ¿ø ¹× ÀçÀÔ¿øÀ» ÃÖ¼ÒÈÇÏ°í º¸´Ù ÇÕ¸®ÀûÀÎ ÀÇ·á °æÇèÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡Àº ÀÇ·á ¼ºñ½º Á¦°øÀÇ ÀÓ»óÀû Ãø¸é°ú ¿î¿µÀû Ãø¸éÀ» ¸ðµÎ °³¼±ÇÏ¿© ¾çÁúÀÇ, ºñ¿ë È¿À²ÀûÀ̸ç ȯÀÚ Áß½ÉÀÇ Ä¡·á¶ó´Â ¸ñÇ¥¸¦ Áö¿øÇÕ´Ï´Ù.
ȯÀÚ Ç÷¾× °ü¸® ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?
ȯÀÚ Ç÷¾× °ü¸® ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¼öÇ÷ °ü·Ã À§Çè¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¼ö¼ú ¹× ¸¸¼ºÁúȯ »ç·Ê Áõ°¡, Áø´Ü ¹× Ä¡·á ±â¼ú ¹ßÀü, PBM µµÀÔÀ» ÃËÁøÇÏ´Â ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø Á¤Ã¥ µîÀÌ ÀÖ½À´Ï´Ù. ¼öÇ÷°ú °ü·ÃµÈ À§Çè°ú ÇÕº´Áõ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº ±âÁ¸ÀÇ ¼öÇ÷ ¹æ¹ýÀ» ´ëüÇÒ ¼ö ÀÖ´Â º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀÎ ¹æ¹ýÀ» ã°í ÀÖ½À´Ï´Ù. °¨¿°, ¸é¿ªÇÐÀû ¹ÝÀÀ, ÀáÀçÀû ÇÕº´Áõ¿¡ ´ëÇÑ ¿ì·Á´Â ¼öÇ÷À» ÃÖ¼ÒÈÇÏ°í º¸´Ù ¾ÈÀüÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÏ´Â PBM ÇÁ·Î±×·¥ÀÇ Çʿ伺À» °Á¶Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÓ»óÀû °üÁ¡ÀÇ º¯È·Î ÀÎÇØ ´õ ¸¹Àº º´¿ø°ú ÀÇ·á ±â°üÀÌ PBM ÇÁ·ÎÅäÄÝÀ» äÅÃÇϰí ÀÖÀ¸¸ç, Á¾ÇÕÀûÀÎ Ç÷¾× °ü¸®¸¦ Áö¿øÇÏ´Â ±â¼ú°ú ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¼ö¼ú °Ç¼ö Áõ°¡¿Í ¾Ï, ½ÅÀåÁúȯ, ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡µµ PBM ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº ¼ö¼úÀ̳ª ÀæÀº ÀÔ¿øÀ» ÇÊ¿ä·Î ÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ÀÇ·áÁøÀº ¼öÇ÷¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀÌ¸é¼ È¯ÀÚ Ä¡·á¸¦ Áö¿øÇÏ´Â È¿°úÀûÀÎ Ç÷¾× °ü¸® Àü·«ÀÌ ÇÊ¿äÇϸç, PBM ÇÁ·ÎÅäÄÝÀº ¼ö¼ú Àü°ú ¼ö¼ú Áß È¯ÀÚÀÇ Ç÷¾× »óŸ¦ ÃÖÀûÈÇÏ¿© ¼öÇ÷ÀÇ Çʿ伺À» ÁÙ¿©ÁÝ´Ï´Ù. ¼öÇ÷ÀÇ Çʿ伺À» ÁÙÀÏ ¼ö ÀÖÀ¸¹Ç·Î ÃâÇ÷ÀÌ ¸¹Àº ¼ö¼ú¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¼ö¼ú ¹× ÀÔ¿ø °Ç¼ö°¡ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó Ç÷¾×À» È¿À²ÀûÀ¸·Î °ü¸®Çϰí ȯÀÚ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇÑ È¿°úÀûÀÎ PBM ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äµµ °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
Áø´Ü ¹× Ä¡·á ±â¼úÀÇ ¹ßÀüÀº º¸´Ù Á¤È®Çϰí È¿°úÀûÀÎ ¸ÂÃãÇü Ç÷¾× °ü¸® Àü·«À» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á PBM ½ÃÀåÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÇöÀå °Ë»ç ¹× °í±Þ ºóÇ÷ ¼±º°°Ë»ç¿Í °°Àº »õ·Î¿î Áø´Ü ÅøÀº ȯÀÚÀÇ Ç÷¾× ¼öÄ¡¸¦ Á¶±â¿¡ °³ÀÔÇϰí Á¤È®ÇÏ°Ô °ü¸®ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¼¼Æ÷ ±¸Á¦ Àåºñ¿Í ÃÖ¼Òħ½ÀÀû ¼ö¼ú¹ýÀ» Æ÷ÇÔÇÑ ¿Ü°úÀû Çõ½ÅÀº ¼ö¼ú Áß Ç÷¾× ¼Õ½ÇÀ» ÁÙÀÌ°í °ø¿© Ç÷¾×ÀÇ Çʿ伺À» ÃÖ¼ÒÈÇÕ´Ï´Ù. ÀûÇ÷±¸ Á¶Ç÷ ÃËÁøÁ¦ ¹× Á¤¸Æ³» öºÐ º¸ÃæÁ¦ µî ÀǾàǰÀÇ ¹ßÀüÀº ºóÇ÷ ȯÀÚ¿¡°Ô ¼öÇ÷ ÀÌ¿ÜÀÇ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº PBM ÇÁ·Î±×·¥À» º¸´Ù ½±°í È¿°úÀûÀ¸·Î ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô ÇØÁÖ°í, Àü ¼¼°è º´¿ø°ú ÀÇ·á ½Ã¼³¿¡¼ PBM ÇÁ·Î±×·¥ÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀÇ·á ±â°ü°ú Á¤ºÎ°¡ ȯÀÚ ¾ÈÀüÀ» °³¼±Çϰí Ç÷¾× ÀÚ¿øÀ» ÃÖÀûÈÇÏ´Â µ¥ ÀÖÀ¸¸ç, PBMÀÇ °¡Ä¡¸¦ ÀνÄÇÔ¿¡ µû¶ó PBM ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇÏ´Â ±ÔÁ¦ Á¤Ã¥°ú °¡À̵å¶óÀεµ PBM ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿Í °°Àº ±ÔÁ¦±â°ü°ú ¿©·¯ ±¹°¡ÀÇ º¸°ÇºÎ´Â ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ Ç¥ÁØ Ä¡·á ÇÁ·ÎÅäÄÝÀÇ ÀϺηΠPBMÀ» äÅÃÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ÇöÀç ¸¹Àº ÀÇ·á ½Ã½ºÅÛÀº ǰÁú Ç¥ÁØÀ» ÁؼöÇϰí ÀÇ·á ºñ¿ëÀ» Àý°¨Çϸç Ç÷¾× ÀÚ¿øÀ» Àý¾àÇϱâ À§ÇØ º´¿ø¿¡ PBM Àü·«À» ½ÃÇàÇϵµ·Ï ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ ¿ËÈ£ ´Üü¿Í ÀÇ·á ±â°üÀº ÀÇ·á Á¾»çÀÚ¿Í ÀÏ¹Ý ´ëÁß¿¡°Ô PBMÀÇ ÀÌÁ¡À» ¾Ë¸®±â À§ÇØ ±³À° Ȱµ¿À» °ÈÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦¿Í ¿ËÈ£ ³ë·ÂÀº PBMÀÇ Ã¤ÅÃÀ» È®´ëÇϰí ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ º£½ºÆ® ÇÁ·¢Æ¼½º¿Í ÄÄÇöóÀ̾𽺠ǥÁØÀ» ÁؼöÇÔ¿¡ µû¶ó ½ÃÀåÀÇ Å« ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
¼öÇ÷ À§Çè¿¡ ´ëÇÑ ÀνÄ, ¼ö¼ú ¹× ¸¸¼ºÁúȯ Áõ°¡, ±â¼ú ¹ßÀü, Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© µî ´Ù¾çÇÑ ¿äÀÎÀÌ °áÇյǾî ȯÀÚ Ç÷¾× °ü¸® ½ÃÀåÀº °·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ º¸´Ù ¾ÈÀüÇÏ°í ºñ¿ë È¿À²ÀûÀ̸ç ÀÚ¿ø È¿À²ÀûÀÎ ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ´Â °¡¿îµ¥, PBMÀº ȯÀÚ Áß½ÉÀÇ Çö´ëÀû ÀÇ·á ¼ºñ½º Á¦°øÀÇ Ãʼ®ÀÌ µÇ°í ÀÖ½À´Ï´Ù.
ºÎ¹®
Á¦Ç°(Àåºñ, ½Ã¾à & ŰƮ, ¼ÒÇÁÆ®¿þ¾î, ¾×¼¼¼¸®);¼ººÐ(ÀüÇ÷ & ÀûÇ÷±¸, Ç÷Àå);ÃÖÁ¾ »ç¿ë(Ç÷¾×ÀºÇà, º´¿ø)
Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 42»ç)
- Abbott Laboratories
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
- Biomerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche LTD.
- Fresenius Se & Co. KGaA
- Grifols, S.A.
- Haemonetics Corporation
- Immucor, Inc.
- Kaneka Corporation
- Livanova PLC
- Macopharma
- Terumo Corporation
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý
Á¦2Àå °³¿ä
- ½ÃÀå °³¿ä
- ÁÖ¿ä ±â¾÷
- ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
- ¼¼°è ½ÃÀåÀÇ Àü¸Á
Á¦3Àå ½ÃÀå ºÐ¼®
- ¹Ì±¹
- ij³ª´Ù
- ÀϺ»
- Áß±¹
- À¯·´
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ¿µ±¹
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- È£ÁÖ
- Àεµ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¾Æ¸£ÇîÆ¼³ª
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- À̶õ
- À̽º¶ó¿¤
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
Á¦4Àå °æÀï
KSA
Global Patient Blood Management Market to Reach US$23.6 Billion by 2030
The global market for Patient Blood Management estimated at US$15.2 Billion in the year 2023, is expected to reach US$23.6 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Instruments, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$10.1 Billion by the end of the analysis period. Growth in the Reagents & Kits segment is estimated at 7.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 9.8% CAGR
The Patient Blood Management market in the U.S. is estimated at US$4.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Global Patient Blood Management Market - Key Trends & Drivers Summarized
Why Is Patient Blood Management Essential in Modern Healthcare?
Patient Blood Management (PBM) has become a crucial component in modern healthcare, providing a systematic approach to optimize the care of patients who might need blood transfusions. PBM focuses on minimizing the need for blood transfusions by managing anemia, reducing blood loss during surgery, and optimizing patients' red blood cell mass, thereby improving clinical outcomes. The importance of PBM lies in its ability to enhance patient safety by reducing the risks associated with transfusions, such as infections, immune reactions, and transfusion-related complications. This evidence-based approach is especially important for patients undergoing surgeries, trauma cases, or those with chronic anemia, as it reduces dependency on blood products and leads to faster recovery.
By minimizing unnecessary transfusions, PBM also plays a significant role in conserving blood supplies, which are often in limited availability. This approach is vital for healthcare systems, particularly in times of blood shortages or in regions with limited access to blood products. With the rising demand for blood due to aging populations and increasing surgical procedures, PBM ensures that blood is available for patients who need it most while encouraging efficient blood use. This practice not only conserves resources but also lowers healthcare costs associated with blood transfusions, making PBM essential for sustainable healthcare management.
Moreover, PBM promotes better overall outcomes by taking a preventive, individualized approach to managing each patient's blood needs. Through interventions like iron supplementation, erythropoiesis-stimulating agents, and advanced surgical techniques, PBM prepares patients adequately before surgery or treatment. This comprehensive approach reduces the likelihood of complications, shortens hospital stays, and enhances recovery times. As healthcare increasingly emphasizes patient-centered care, PBM provides a tailored, preventive strategy that aligns with modern principles of healthcare delivery, improving both patient satisfaction and health outcomes.
How Are Technological Advancements Enhancing Patient Blood Management?
Technological advancements are significantly enhancing Patient Blood Management by introducing new tools and methods that optimize blood use, minimize blood loss, and improve patient outcomes. One key innovation in PBM is the development of advanced diagnostic tools that allow for early detection and management of anemia before surgery or treatment. Technologies like point-of-care (POC) testing and automated blood analyzers enable rapid hemoglobin assessments and iron deficiency evaluations, allowing healthcare providers to diagnose and treat anemia early. With accurate, real-time diagnostics, clinicians can implement personalized strategies to optimize hemoglobin levels in advance, reducing the likelihood of needing transfusions. These technologies support proactive anemia management, a core component of PBM, ensuring that patients are in the best possible condition before undergoing procedures.
Another major advancement in PBM is the use of cell salvage and blood-sparing surgical techniques, which minimize blood loss and reduce transfusion needs during surgery. Intraoperative cell salvage devices collect and process a patient’s blood during surgery, allowing it to be reinfused back into the patient, thus reducing dependency on donor blood. Additionally, minimally invasive and laparoscopic surgical techniques are becoming increasingly common, as they involve smaller incisions, leading to less blood loss. These techniques are particularly beneficial in high-blood-loss surgeries, such as orthopedic and cardiac procedures. By incorporating cell salvage and minimally invasive techniques, PBM reduces the need for external blood, improving surgical outcomes and supporting resource efficiency.
Pharmaceutical innovations, such as erythropoiesis-stimulating agents (ESAs) and iron supplements, are also playing a critical role in PBM by boosting red blood cell production and addressing anemia without the need for transfusions. ESAs stimulate the bone marrow to produce more red blood cells, which is especially beneficial for patients with chronic anemia or those undergoing chemotherapy. Iron supplements, whether oral or intravenous, support hemoglobin optimization, preparing patients for procedures that may involve blood loss. With these pharmaceutical interventions, PBM offers non-transfusion options for managing anemia, aligning with its goal to enhance patient health while minimizing transfusion requirements. These therapies empower clinicians to tailor PBM strategies to each patient’s needs, providing a more effective and less invasive approach to blood management.
What Are the Benefits of Patient Blood Management for Patients and Healthcare Providers?
Patient Blood Management provides significant benefits for both patients and healthcare providers, improving patient outcomes, reducing healthcare costs, and optimizing the use of limited blood supplies. For patients, PBM enhances safety by minimizing the risks associated with blood transfusions, such as infections, transfusion reactions, and immunologic complications. By employing non-transfusion interventions like anemia management, surgical blood-sparing techniques, and the use of patient’s own blood, PBM reduces the potential for adverse reactions and promotes a safer healthcare experience. For patients undergoing major surgeries, PBM offers the assurance of a carefully managed blood strategy that prioritizes their health, reduces the need for transfusions, and leads to quicker recovery times and shorter hospital stays.
For healthcare providers, PBM supports efficient and sustainable resource management by reducing reliance on donor blood, which is often in limited supply. With blood donation rates unable to keep pace with increasing demand, PBM helps preserve blood resources for patients with critical needs, such as trauma or severe bleeding cases. By reducing blood usage through optimized care and non-transfusion interventions, healthcare providers can manage resources more effectively, lowering the risk of blood shortages and ensuring that blood products are available when truly necessary. PBM also decreases costs associated with blood transfusions, including storage, screening, and administration expenses. This cost-efficiency is especially valuable in large hospitals and health systems, where managing blood resources effectively can lead to substantial financial savings.
Enhanced patient outcomes and quality of care are additional benefits of PBM, as it fosters a more patient-centered, individualized approach to healthcare. Through early anemia detection, blood-sparing surgical practices, and non-transfusion options, PBM enables healthcare providers to create personalized care plans tailored to each patient’s needs. This customized approach reduces the likelihood of complications and supports faster recoveries, improving patient satisfaction and overall quality of care. By proactively managing patients’ blood health, PBM minimizes hospital stays and readmissions, leading to a more streamlined healthcare experience. Together, these benefits improve both the clinical and operational aspects of healthcare delivery, supporting the goal of high-quality, cost-effective, and patient-centered care.
What Is Fueling the Growth in the Patient Blood Management Market?
The growth in the Patient Blood Management market is driven by the rising awareness of transfusion-related risks, increasing surgical and chronic disease cases, advancements in diagnostic and therapeutic technologies, and supportive regulatory policies promoting PBM adoption. As awareness grows around the risks and complications associated with blood transfusions, healthcare providers are increasingly seeking safer and more effective alternatives to traditional transfusion practices. Concerns over infections, immunologic reactions, and potential complications have highlighted the need for PBM programs that minimize transfusions and provide safer care options. This shift in clinical perspective has encouraged more hospitals and healthcare facilities to adopt PBM protocols, driving demand for technologies and practices that support comprehensive blood management.
Increasing numbers of surgeries and the rising prevalence of chronic diseases, such as cancer, kidney disease, and cardiovascular conditions, are also fueling the demand for PBM solutions. With these conditions often requiring surgical interventions or frequent hospitalizations, healthcare providers need effective blood management strategies to support patient care while reducing transfusion dependency. PBM protocols are particularly valuable in high-blood-loss surgeries, as they optimize patient blood health before and during procedures, decreasing the need for transfusions. As the volume of surgeries and hospitalizations continues to grow, so does the demand for effective PBM solutions to manage blood efficiently and improve patient outcomes.
Advancements in diagnostic and therapeutic technologies are significantly contributing to PBM market growth, as they enable more precise, effective, and personalized blood management strategies. New diagnostic tools, such as point-of-care testing and advanced anemia screening, allow for early intervention and accurate management of patient blood levels. Surgical innovations, including cell salvage devices and minimally invasive techniques, reduce blood loss during procedures, minimizing the need for donor blood. Pharmaceutical advancements, such as erythropoiesis-stimulating agents and intravenous iron supplements, provide non-transfusion treatment options for patients with anemia. These technological innovations make PBM programs more accessible and effective, supporting their adoption in hospitals and healthcare facilities worldwide.
Supportive regulatory policies and guidelines are also driving growth in the PBM market, as healthcare organizations and governments recognize the value of PBM in improving patient safety and optimizing blood resources. Regulatory bodies like the World Health Organization (WHO) and health ministries in several countries are encouraging healthcare providers to adopt PBM practices as part of their standard care protocols. Many healthcare systems now require hospitals to implement PBM strategies to comply with quality standards, reduce healthcare costs, and conserve blood resources. Additionally, patient advocacy groups and health organizations have increased educational efforts to promote awareness of PBM benefits among healthcare professionals and the public. These regulatory and advocacy efforts are expanding the adoption of PBM, driving significant growth in the market as providers align with best practices and compliance standards.
Together, these factors—awareness of transfusion risks, increasing surgical and chronic disease prevalence, technological advancements, and supportive regulatory frameworks—are driving robust growth in the Patient Blood Management market. As healthcare systems aim to provide safer, more cost-effective, and resource-efficient care, PBM is becoming a cornerstone of modern, patient-centered healthcare delivery.
SCOPE OF STUDY:
The report analyzes the Patient Blood Management market in terms of US$ Million by the following Component; End-Use; Product, and Geographic Regions/Countries:
Segments:
Product (Instruments, Reagents & Kits, Software, Accessories); Component (Whole Blood & Red Blood Cells, Plasma); End-Use (Blood Banks, Hospitals)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
- Abbott Laboratories
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
- Biomerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche LTD.
- Fresenius Se & Co. KGaA
- Grifols, S.A.
- Haemonetics Corporation
- Immucor, Inc.
- Kaneka Corporation
- Livanova PLC
- Macopharma
- Terumo Corporation
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Patient Blood Management - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Increasing Focus on Blood Conservation Drives Demand for Patient Blood Management (PBM) Solutions
- Rising Incidence of Chronic Diseases Expands Addressable Market for PBM
- Advancements in Blood Transfusion Technologies Propel Market Growth
- Growing Use of Point-of-Care Hemoglobin Testing Drives PBM Solutions
- Patient Blood Management Crucial for Enhancing Surgical Outcomes
- Use of AI for Blood Utilization Optimization Sets the Stage for PBM Growth
- Increasing Demand for Bloodless Surgery Expands PBM Applications
- Innovations in Anemia Management Propel PBM Market Expansion
- Focus on Reducing Blood Transfusion-Related Risks Drives PBM Adoption
- Use of PBM in Oncology Care Expands Market Opportunities
- Growing Adoption in Emergency and Trauma Care Expands PBM Applications
- Use of PBM in Geriatric Care Strengthens Market Opportunities
- Strategic Investments in Automated Blood Management Solutions Propel PBM Growth
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Patient Blood Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 14: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 15: World 16-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 17: World Historic Review for Whole Blood & Red Blood Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 18: World 16-Year Perspective for Whole Blood & Red Blood Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 19: World Recent Past, Current & Future Analysis for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 20: World Historic Review for Plasma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 21: World 16-Year Perspective for Plasma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 22: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 23: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 24: World 16-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 27: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 28: World Patient Blood Management Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
- UNITED STATES
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 29: USA Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 30: USA Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: USA 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 32: USA Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: USA 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: USA 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- CANADA
- TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 39: Canada Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: Canada 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 41: Canada Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: Canada 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 44: Canada Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: Canada 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- JAPAN
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 47: Japan Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: Japan Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: Japan 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 50: Japan Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: Japan Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: Japan 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 53: Japan Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: Japan 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- CHINA
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 56: China Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 57: China Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: China 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 59: China Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: China Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: China 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: China Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: China 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- EUROPE
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 65: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 66: Europe Historic Review for Patient Blood Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: Europe 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 68: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: Europe 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 71: Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Europe 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Europe 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- FRANCE
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 77: France Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: France Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: France 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 80: France Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: France Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: France 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 83: France Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: France Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: France 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- GERMANY
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 86: Germany Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: Germany Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: Germany 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 89: Germany Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: Germany Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Germany 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 92: Germany Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: Germany 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- ITALY
- TABLE 95: Italy Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 96: Italy Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: Italy 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 98: Italy Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: Italy Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Italy 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 101: Italy Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Italy 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- UNITED KINGDOM
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 104: UK Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: UK Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: UK 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 107: UK Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 108: UK Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: UK 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 110: UK Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: UK 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- SPAIN
- TABLE 113: Spain Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 114: Spain Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 115: Spain 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 116: Spain Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 117: Spain Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 118: Spain 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 119: Spain Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 120: Spain Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 121: Spain 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- RUSSIA
- TABLE 122: Russia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 123: Russia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 124: Russia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 125: Russia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 126: Russia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 127: Russia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 128: Russia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 129: Russia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 130: Russia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- REST OF EUROPE
- TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 132: Rest of Europe Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 133: Rest of Europe 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 135: Rest of Europe Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 136: Rest of Europe 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 138: Rest of Europe Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 139: Rest of Europe 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- ASIA-PACIFIC
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 141: Asia-Pacific Historic Review for Patient Blood Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 142: Asia-Pacific 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 144: Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 145: Asia-Pacific 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 147: Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 148: Asia-Pacific 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 151: Asia-Pacific 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- AUSTRALIA
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 152: Australia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 153: Australia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 154: Australia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 155: Australia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 156: Australia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 157: Australia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 158: Australia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 159: Australia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 160: Australia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- INDIA
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 161: India Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 162: India Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 163: India 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 164: India Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 165: India Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 166: India 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 167: India Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 168: India Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 169: India 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- SOUTH KOREA
- TABLE 170: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 171: South Korea Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 172: South Korea 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 173: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 174: South Korea Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 175: South Korea 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 176: South Korea Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 177: South Korea Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 178: South Korea 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- REST OF ASIA-PACIFIC
- TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 180: Rest of Asia-Pacific Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 183: Rest of Asia-Pacific Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 186: Rest of Asia-Pacific Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- LATIN AMERICA
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 188: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 189: Latin America Historic Review for Patient Blood Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 190: Latin America 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 191: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 192: Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 193: Latin America 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 194: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 195: Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 196: Latin America 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 199: Latin America 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- ARGENTINA
- TABLE 200: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 201: Argentina Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 202: Argentina 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 203: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 204: Argentina Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 205: Argentina 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 206: Argentina Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 207: Argentina Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 208: Argentina 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- BRAZIL
- TABLE 209: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 210: Brazil Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 211: Brazil 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 212: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 213: Brazil Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 214: Brazil 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 215: Brazil Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 216: Brazil Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 217: Brazil 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- MEXICO
- TABLE 218: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 219: Mexico Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 220: Mexico 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 221: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 222: Mexico Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 223: Mexico 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 224: Mexico Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 225: Mexico Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 226: Mexico 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- REST OF LATIN AMERICA
- TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 228: Rest of Latin America Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 229: Rest of Latin America 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 231: Rest of Latin America Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 232: Rest of Latin America 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 234: Rest of Latin America Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 235: Rest of Latin America 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- MIDDLE EAST
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 236: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 237: Middle East Historic Review for Patient Blood Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 238: Middle East 16-Year Perspective for Patient Blood Management by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 239: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 240: Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 241: Middle East 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 242: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 243: Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 244: Middle East 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 247: Middle East 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- IRAN
- TABLE 248: Iran Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 249: Iran Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 250: Iran 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 251: Iran Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 252: Iran Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 253: Iran 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 254: Iran Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 255: Iran Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 256: Iran 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- ISRAEL
- TABLE 257: Israel Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 258: Israel Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 259: Israel 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 260: Israel Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 261: Israel Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 262: Israel 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 263: Israel Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 264: Israel Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 265: Israel 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- SAUDI ARABIA
- TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 267: Saudi Arabia Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 268: Saudi Arabia 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 270: Saudi Arabia Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 271: Saudi Arabia 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 273: Saudi Arabia Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 274: Saudi Arabia 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- UNITED ARAB EMIRATES
- TABLE 275: UAE Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 276: UAE Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 277: UAE 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 278: UAE Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 279: UAE Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 280: UAE 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 281: UAE Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 282: UAE Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 283: UAE 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- REST OF MIDDLE EAST
- TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 285: Rest of Middle East Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 286: Rest of Middle East 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 288: Rest of Middle East Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 289: Rest of Middle East 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 291: Rest of Middle East Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 292: Rest of Middle East 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
- AFRICA
- Patient Blood Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 293: Africa Recent Past, Current & Future Analysis for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 294: Africa Historic Review for Patient Blood Management by Product - Instruments, Reagents & Kits, Software and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 295: Africa 16-Year Perspective for Patient Blood Management by Product - Percentage Breakdown of Value Sales for Instruments, Reagents & Kits, Software and Accessories for the Years 2014, 2024 & 2030
- TABLE 296: Africa Recent Past, Current & Future Analysis for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 297: Africa Historic Review for Patient Blood Management by Component - Whole Blood & Red Blood Cells and Plasma Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 298: Africa 16-Year Perspective for Patient Blood Management by Component - Percentage Breakdown of Value Sales for Whole Blood & Red Blood Cells and Plasma for the Years 2014, 2024 & 2030
- TABLE 299: Africa Recent Past, Current & Future Analysis for Patient Blood Management by End-Use - Blood Banks and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 300: Africa Historic Review for Patient Blood Management by End-Use - Blood Banks and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 301: Africa 16-Year Perspective for Patient Blood Management by End-Use - Percentage Breakdown of Value Sales for Blood Banks and Hospitals for the Years 2014, 2024 & 2030
IV. COMPETITION